Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Revance Therapeutics Charts.

Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Revance Therapeutics Charts.

Revance Therapeutics Inc News

Form 15-12G - Securities registration termination [Section 12(g)]
Tuesday 18 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC
Thursday 13 February 2025 (4 weeks ago) • PR Newswire (US)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Wednesday 12 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form POSASR - Post-effective Amendment to an automatic shelf registration statement
Wednesday 12 February 2025 (4 weeks ago) • Edgar (US Regulatory)

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc.(RVNC) Shareholders
Monday 10 February 2025 (4 weeks ago) • PR Newswire (US)

Crown Laboratories Completes Acquisition of Revance Therapeutics
Friday 7 February 2025 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

More Revance Therapeutics Inc News Articles

HOTEIS OTHON PN

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions